Technical Analysis for FENC - Fennec Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 6.98 -3.19% -0.23
FENC closed down 3.19 percent on Friday, January 18, 2019, on 69 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical FENC trend table...

Date Alert Name Type % Chg
Jan 17 Pocket Pivot Bullish Swing Setup -3.19%
Jan 17 Stochastic Reached Overbought Strength -3.19%
Jan 17 Inside Day Range Contraction -3.19%
Jan 17 Wide Bands Range Expansion -3.19%
Jan 17 Overbought Stochastic Strength -3.19%
Jan 17 Up 3 Days in a Row Strength -3.19%
Jan 16 Wide Bands Range Expansion -2.38%
Jan 15 Pocket Pivot Bullish Swing Setup -2.10%
Jan 15 Wide Bands Range Expansion -2.10%
Jan 14 Narrow Range Bar Range Contraction -0.14%

Older signals for FENC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Fennec Pharmaceuticals Inc., formerly Adherex Technologies Inc., is a biopharmaceutical company focused on cancer therapeutics. The Company's lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children. STS has been studied by cooperative groups in over two Phase III clinical studies of survival and reduction of ototoxicity, The Clinical Oncology Group Protocol ACCL0431 and SIOPEL 6. The Children's Oncology Group (COG) ACCL0431 protocol enrolled 20% childhood cancers typically treated with intensive cisplatin therapy for localized and disseminated disease, including hepatoblastoma, germ cell tumor, osteosarcoma, neuroblastoma and medulloblastoma. SIOPEL 6 enrolled only hepatoblastoma patients with localized tumors.
Is FENC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.99
52 Week Low 5.33
Average Volume 67,057
200-Day Moving Average 9.1847
50-Day Moving Average 6.691
20-Day Moving Average 6.7195
10-Day Moving Average 7.111
Average True Range 0.3512
ADX 28.62
+DI 23.9803
-DI 13.9044
Chandelier Exit (Long, 3 ATRs ) 6.3864
Chandelier Exit (Short, 3 ATRs ) 6.3836
Upper Bollinger Band 7.5766
Lower Bollinger Band 5.8624
Percent B (%b) 0.65
BandWidth 25.510827
MACD Line 0.1766
MACD Signal Line 0.1208
MACD Histogram 0.0558
Fundamentals Value
Market Cap 110.05 Million
Num Shares 15.8 Million
EPS -0.29
Price-to-Earnings (P/E) Ratio -24.07
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.34
Resistance 3 (R3) 7.38 7.29 7.28
Resistance 2 (R2) 7.29 7.20 7.28 7.26
Resistance 1 (R1) 7.14 7.15 7.10 7.10 7.24
Pivot Point 7.05 7.05 7.03 7.04 7.05
Support 1 (S1) 6.90 6.96 6.86 6.86 6.72
Support 2 (S2) 6.81 6.91 6.80 6.70
Support 3 (S3) 6.66 6.81 6.68
Support 4 (S4) 6.62